Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.44956573 |
2 | neutrophil activation involved in immune response (GO:0002283) | 4.95406860 |
3 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.80999986 |
4 | cellular extravasation (GO:0045123) | 4.37124141 |
5 | superoxide anion generation (GO:0042554) | 4.36871074 |
6 | positive regulation by symbiont of host defense response (GO:0052509) | 4.27662120 |
7 | modulation by symbiont of host defense response (GO:0052031) | 4.27662120 |
8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.27662120 |
9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.27662120 |
10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.27662120 |
11 | modulation by symbiont of host immune response (GO:0052553) | 4.27662120 |
12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.17141442 |
13 | negative regulation of cell killing (GO:0031342) | 4.17141442 |
14 | response to peptidoglycan (GO:0032494) | 4.00383179 |
15 | central nervous system myelination (GO:0022010) | 3.87524227 |
16 | axon ensheathment in central nervous system (GO:0032291) | 3.87524227 |
17 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.85672358 |
18 | regulation of gamma-delta T cell activation (GO:0046643) | 3.85430409 |
19 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.81538228 |
20 | neutrophil activation (GO:0042119) | 3.69378082 |
21 | respiratory burst (GO:0045730) | 3.69275041 |
22 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.68923241 |
23 | detection of other organism (GO:0098543) | 3.56804244 |
24 | leukocyte degranulation (GO:0043299) | 3.51514934 |
25 | granulocyte activation (GO:0036230) | 3.47309739 |
26 | positive regulation of granulocyte differentiation (GO:0030854) | 3.45061782 |
27 | natural killer cell activation involved in immune response (GO:0002323) | 3.36517650 |
28 | microglial cell activation (GO:0001774) | 3.32981316 |
29 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.28856699 |
30 | detection of bacterium (GO:0016045) | 3.21665737 |
31 | positive regulation of B cell differentiation (GO:0045579) | 3.18841848 |
32 | regulation of regulatory T cell differentiation (GO:0045589) | 3.17295543 |
33 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.16464539 |
34 | T-helper 1 type immune response (GO:0042088) | 3.15692371 |
35 | detection of molecule of bacterial origin (GO:0032490) | 3.14879184 |
36 | response to host immune response (GO:0052572) | 3.13011106 |
37 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.13011106 |
38 | response to interleukin-15 (GO:0070672) | 3.12230227 |
39 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.11481058 |
40 | macrophage activation involved in immune response (GO:0002281) | 3.10396576 |
41 | B cell receptor signaling pathway (GO:0050853) | 3.10017775 |
42 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.09987755 |
43 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.05367093 |
44 | positive regulation of heat generation (GO:0031652) | 3.03778223 |
45 | hepatocyte apoptotic process (GO:0097284) | 3.01752493 |
46 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.00552527 |
47 | positive regulation of antigen processing and presentation (GO:0002579) | 3.00203230 |
48 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.00184823 |
49 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.99443344 |
50 | sphingosine metabolic process (GO:0006670) | 2.99131178 |
51 | detection of external biotic stimulus (GO:0098581) | 2.97133837 |
52 | regulation of heat generation (GO:0031650) | 2.93424640 |
53 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.92062533 |
54 | regulation of activation of Janus kinase activity (GO:0010533) | 2.91431820 |
55 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.90815832 |
56 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.90484600 |
57 | reactive oxygen species biosynthetic process (GO:1903409) | 2.88447962 |
58 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.88314359 |
59 | negative thymic T cell selection (GO:0045060) | 2.87673074 |
60 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.87504743 |
61 | cellular response to interleukin-15 (GO:0071350) | 2.83545033 |
62 | embryonic process involved in female pregnancy (GO:0060136) | 2.82163058 |
63 | positive regulation of tolerance induction (GO:0002645) | 2.81167055 |
64 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.80350409 |
65 | macrophage activation (GO:0042116) | 2.80194476 |
66 | B cell mediated immunity (GO:0019724) | 2.80140547 |
67 | diol metabolic process (GO:0034311) | 2.79833289 |
68 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.79678912 |
69 | regulation of fever generation (GO:0031620) | 2.79321245 |
70 | regulation of tolerance induction (GO:0002643) | 2.77882629 |
71 | fatty acid elongation (GO:0030497) | 2.77751136 |
72 | sphingoid metabolic process (GO:0046519) | 2.76895780 |
73 | negative T cell selection (GO:0043383) | 2.76510764 |
74 | negative regulation of T cell mediated immunity (GO:0002710) | 2.76442587 |
75 | phagosome maturation (GO:0090382) | 2.75935728 |
76 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.75763753 |
77 | negative regulation of interleukin-12 production (GO:0032695) | 2.75579202 |
78 | growth hormone receptor signaling pathway (GO:0060396) | 2.75400882 |
79 | regulation of B cell differentiation (GO:0045577) | 2.75276617 |
80 | tolerance induction (GO:0002507) | 2.74217439 |
81 | neutrophil mediated immunity (GO:0002446) | 2.73050961 |
82 | positive regulation of interferon-alpha production (GO:0032727) | 2.72219354 |
83 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.72003187 |
84 | response to muramyl dipeptide (GO:0032495) | 2.69599557 |
85 | superoxide metabolic process (GO:0006801) | 2.69496221 |
86 | myeloid cell activation involved in immune response (GO:0002275) | 2.63421538 |
87 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.62616869 |
88 | L-amino acid import (GO:0043092) | 2.62433066 |
89 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.61821454 |
90 | response to lipoprotein particle (GO:0055094) | 2.61545088 |
91 | regulation of RIG-I signaling pathway (GO:0039535) | 2.61502541 |
92 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.60771981 |
93 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.60400265 |
94 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.59917989 |
95 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.59430232 |
96 | import into cell (GO:0098657) | 2.59359195 |
97 | negative regulation of mast cell activation (GO:0033004) | 2.58576143 |
98 | regulation of antigen processing and presentation (GO:0002577) | 2.58099779 |
99 | regulation of interferon-alpha production (GO:0032647) | 2.57709976 |
100 | natural killer cell differentiation (GO:0001779) | 2.56966636 |
101 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.56927185 |
102 | nucleotide transmembrane transport (GO:1901679) | 2.56838211 |
103 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.56058817 |
104 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.56058817 |
105 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.54031775 |
106 | regulation of necroptotic process (GO:0060544) | 2.53331193 |
107 | negative regulation of adaptive immune response (GO:0002820) | 2.51423387 |
108 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.50618808 |
109 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.50298365 |
110 | intracellular pH reduction (GO:0051452) | 2.50099958 |
111 | dendritic cell migration (GO:0036336) | 2.49968727 |
112 | regulation of mast cell degranulation (GO:0043304) | 2.49503195 |
113 | regulation of T cell tolerance induction (GO:0002664) | 2.49273845 |
114 | histamine secretion (GO:0001821) | 2.48946064 |
115 | detection of biotic stimulus (GO:0009595) | 2.47783814 |
116 | cellular response to growth hormone stimulus (GO:0071378) | 2.46828651 |
117 | T cell selection (GO:0045058) | 2.45935306 |
118 | organelle membrane fusion (GO:0090174) | 2.44501289 |
119 | positive regulation of leukocyte degranulation (GO:0043302) | 2.44431768 |
120 | positive regulation of acute inflammatory response (GO:0002675) | 2.44385777 |
121 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.44160999 |
122 | regulation of mast cell activation (GO:0033003) | 2.43873650 |
123 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.43734410 |
124 | positive regulation of mast cell degranulation (GO:0043306) | 2.43290867 |
125 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.43290867 |
126 | eosinophil chemotaxis (GO:0048245) | 2.42917773 |
127 | positive regulation of humoral immune response (GO:0002922) | 2.42730318 |
128 | negative regulation of lipid storage (GO:0010888) | 2.42702105 |
129 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.42621036 |
130 | response to host (GO:0075136) | 2.42621036 |
131 | response to host defenses (GO:0052200) | 2.42621036 |
132 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.42270122 |
133 | negative regulation of B cell mediated immunity (GO:0002713) | 2.41265394 |
134 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.41265394 |
135 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.40917027 |
136 | regulation of germinal center formation (GO:0002634) | 2.40444374 |
137 | negative regulation of interleukin-17 production (GO:0032700) | 2.40337067 |
138 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.36801808 |
139 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.36724926 |
140 | positive regulation of interleukin-17 production (GO:0032740) | 2.34039659 |
141 | regulation of platelet aggregation (GO:0090330) | 2.34004387 |
142 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.33934293 |
143 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.33233912 |
144 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.32879826 |
145 | dendritic cell chemotaxis (GO:0002407) | 2.31800697 |
146 | regulation of interleukin-17 production (GO:0032660) | 2.31445746 |
147 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.30234105 |
148 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.28572672 |
149 | regulation of growth of symbiont in host (GO:0044126) | 2.28572672 |
150 | negative regulation of growth of symbiont in host (GO:0044130) | 2.28572672 |
151 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.28572672 |
152 | immunoglobulin mediated immune response (GO:0016064) | 2.28157644 |
153 | defense response to protozoan (GO:0042832) | 2.27698759 |
154 | leukocyte aggregation (GO:0070486) | 2.27380905 |
155 | positive regulation of type 2 immune response (GO:0002830) | 2.26647984 |
156 | positive regulation of mast cell activation (GO:0033005) | 2.26193605 |
157 | amyloid precursor protein catabolic process (GO:0042987) | 2.25344238 |
158 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.24615202 |
159 | positive regulation of T cell migration (GO:2000406) | 2.24547773 |
160 | glycerophospholipid catabolic process (GO:0046475) | 2.22806713 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.56100152 |
2 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.54344700 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.51615549 |
4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.14037975 |
5 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.84644729 |
6 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.51821605 |
7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.42977630 |
8 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.41289384 |
9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.37979996 |
10 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.22026243 |
11 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.22003110 |
12 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.18525167 |
13 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.18464924 |
14 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.11952116 |
15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.10320227 |
16 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.06123845 |
17 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.04929593 |
18 | MYB_26560356_Chip-Seq_TH2_Human | 2.04629650 |
19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.03621818 |
20 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.02374071 |
21 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.95837795 |
22 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.93745080 |
23 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.91619385 |
24 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.91578484 |
25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.90632463 |
26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.81768651 |
27 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.80517654 |
28 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.78057913 |
29 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.77801959 |
30 | SPI1_23127762_ChIP-Seq_K562_Human | 1.75884142 |
31 | * MYB_26560356_Chip-Seq_TH1_Human | 1.71328450 |
32 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.71029029 |
33 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.70255361 |
34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.65177388 |
35 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.63923683 |
36 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.63665774 |
37 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.62465569 |
38 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.62398862 |
39 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.58395365 |
40 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.57617625 |
41 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.56665635 |
42 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.53225258 |
43 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.52871039 |
44 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.52197400 |
45 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.52148304 |
46 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.51930843 |
47 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.51180102 |
48 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.50392197 |
49 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.49653448 |
50 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.49261259 |
51 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.46305232 |
52 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.46255022 |
53 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.45892260 |
54 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.45843853 |
55 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.45316119 |
56 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.44205352 |
57 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.44205352 |
58 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.41451917 |
59 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.38943519 |
60 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.38117000 |
61 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.37530405 |
62 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.37029216 |
63 | VDR_22108803_ChIP-Seq_LS180_Human | 1.36901867 |
64 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.36237879 |
65 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.35937150 |
66 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.35058185 |
67 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.33979914 |
68 | P300_19829295_ChIP-Seq_ESCs_Human | 1.32685761 |
69 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.32176642 |
70 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.32148464 |
71 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.31374452 |
72 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.31241847 |
73 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.31143560 |
74 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.30927302 |
75 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.27511946 |
76 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.27240181 |
77 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.27108072 |
78 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.26167997 |
79 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.26069999 |
80 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.25624445 |
81 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.25543655 |
82 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.25201865 |
83 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.25025895 |
84 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24194420 |
85 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.23438915 |
86 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.23108139 |
87 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.22992056 |
88 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22210304 |
89 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.21928720 |
90 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.21756481 |
91 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.18938019 |
92 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.16187039 |
93 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.15889910 |
94 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13413963 |
95 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.13272672 |
96 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.12971974 |
97 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.12128380 |
98 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12015300 |
99 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.10604383 |
100 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.09978299 |
101 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.09914606 |
102 | GATA1_22025678_ChIP-Seq_K562_Human | 1.09490048 |
103 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.09096331 |
104 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08523508 |
105 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.08324099 |
106 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08195111 |
107 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07948505 |
108 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.07873775 |
109 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.07119320 |
110 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06887483 |
111 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.05401488 |
112 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.04479055 |
113 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.03913862 |
114 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.03748247 |
115 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.03416263 |
116 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.03173192 |
117 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.02638330 |
118 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.00600932 |
119 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00322268 |
120 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.99801315 |
121 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.95345710 |
122 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.95145521 |
123 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.94967522 |
124 | * KDM2B_26808549_Chip-Seq_REH_Human | 0.94860686 |
125 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.94530831 |
126 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.94442385 |
127 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94334964 |
128 | TP53_16413492_ChIP-PET_HCT116_Human | 0.94246757 |
129 | FUS_26573619_Chip-Seq_HEK293_Human | 0.93876028 |
130 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.93715903 |
131 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.93706173 |
132 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.91648092 |
133 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91559861 |
134 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.91312261 |
135 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91143420 |
136 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91111818 |
137 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91070421 |
138 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90928987 |
139 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90422440 |
140 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.90093638 |
141 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.89657448 |
142 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.88897668 |
143 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.88385167 |
144 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.87301885 |
145 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.87248746 |
146 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87187378 |
147 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.87080986 |
148 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.86901988 |
149 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.86525433 |
150 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.86062192 |
151 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.85378870 |
152 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.85252642 |
153 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.85072839 |
154 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.83990011 |
155 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81696305 |
156 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.81373227 |
157 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.80922119 |
158 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.79196581 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003724_increased_susceptibility_to | 3.61810160 |
2 | MP0001835_abnormal_antigen_presentation | 3.15345927 |
3 | MP0009785_altered_susceptibility_to | 3.02441808 |
4 | MP0002148_abnormal_hypersensitivity_rea | 2.89178381 |
5 | MP0002419_abnormal_innate_immunity | 2.86295234 |
6 | MP0003436_decreased_susceptibility_to | 2.55989124 |
7 | MP0005058_abnormal_lysosome_morphology | 2.55244829 |
8 | MP0003690_abnormal_glial_cell | 2.41850375 |
9 | MP0000920_abnormal_myelination | 2.36251528 |
10 | MP0005025_abnormal_response_to | 2.34808992 |
11 | MP0003136_yellow_coat_color | 2.34741085 |
12 | MP0006082_CNS_inflammation | 2.30433187 |
13 | MP0002277_abnormal_respiratory_mucosa | 2.29689458 |
14 | MP0004381_abnormal_hair_follicle | 2.21752216 |
15 | MP0001790_abnormal_immune_system | 2.21080182 |
16 | MP0005387_immune_system_phenotype | 2.21080182 |
17 | MP0005000_abnormal_immune_tolerance | 2.20920287 |
18 | MP0000465_gastrointestinal_hemorrhage | 2.19366956 |
19 | MP0003763_abnormal_thymus_physiology | 2.17547610 |
20 | MP0006054_spinal_hemorrhage | 2.14455541 |
21 | MP0004782_abnormal_surfactant_physiolog | 2.13036007 |
22 | MP0003191_abnormal_cellular_cholesterol | 2.11305720 |
23 | MP0002396_abnormal_hematopoietic_system | 2.03978008 |
24 | MP0003806_abnormal_nucleotide_metabolis | 2.03439485 |
25 | MP0003656_abnormal_erythrocyte_physiolo | 2.02480993 |
26 | MP0003950_abnormal_plasma_membrane | 1.90300058 |
27 | MP0008057_abnormal_DNA_replication | 1.87998640 |
28 | MP0009764_decreased_sensitivity_to | 1.78684569 |
29 | MP0002452_abnormal_antigen_presenting | 1.76342134 |
30 | MP0002723_abnormal_immune_serum | 1.75458849 |
31 | MP0009840_abnormal_foam_cell | 1.67093680 |
32 | MP0000569_abnormal_digit_pigmentation | 1.65002698 |
33 | MP0001800_abnormal_humoral_immune | 1.62550615 |
34 | MP0005174_abnormal_tail_pigmentation | 1.60944935 |
35 | MP0008260_abnormal_autophagy | 1.60858295 |
36 | MP0005171_absent_coat_pigmentation | 1.59905907 |
37 | MP0001533_abnormal_skeleton_physiology | 1.58092528 |
38 | MP0000015_abnormal_ear_pigmentation | 1.56929931 |
39 | MP0002398_abnormal_bone_marrow | 1.56908804 |
40 | MP0005451_abnormal_body_composition | 1.54168293 |
41 | MP0003300_gastrointestinal_ulcer | 1.54114864 |
42 | MP0005671_abnormal_response_to | 1.48273801 |
43 | MP0003172_abnormal_lysosome_physiology | 1.47368815 |
44 | MP0009333_abnormal_splenocyte_physiolog | 1.46942616 |
45 | MP0003195_calcinosis | 1.43595361 |
46 | MP0000383_abnormal_hair_follicle | 1.42270882 |
47 | MP0001819_abnormal_immune_cell | 1.39172393 |
48 | MP0000689_abnormal_spleen_morphology | 1.38675928 |
49 | MP0005310_abnormal_salivary_gland | 1.37055828 |
50 | MP0002420_abnormal_adaptive_immunity | 1.37006275 |
51 | MP0001188_hyperpigmentation | 1.36977781 |
52 | MP0008469_abnormal_protein_level | 1.36643417 |
53 | MP0004742_abnormal_vestibular_system | 1.33219049 |
54 | MP0002139_abnormal_hepatobiliary_system | 1.31492081 |
55 | MP0001845_abnormal_inflammatory_respons | 1.31473268 |
56 | MP0002722_abnormal_immune_system | 1.30554305 |
57 | MP0002138_abnormal_hepatobiliary_system | 1.28497118 |
58 | MP0005464_abnormal_platelet_physiology | 1.27719983 |
59 | MP0000685_abnormal_immune_system | 1.27386177 |
60 | MP0005085_abnormal_gallbladder_physiolo | 1.25214304 |
61 | MP0002006_tumorigenesis | 1.24076113 |
62 | MP0005379_endocrine/exocrine_gland_phen | 1.23101664 |
63 | MP0002998_abnormal_bone_remodeling | 1.23061367 |
64 | MP0004883_abnormal_blood_vessel | 1.22881272 |
65 | MP0000703_abnormal_thymus_morphology | 1.22778984 |
66 | MP0002429_abnormal_blood_cell | 1.19731906 |
67 | MP0000343_altered_response_to | 1.19566286 |
68 | MP0004019_abnormal_vitamin_homeostasis | 1.18291678 |
69 | MP0003866_abnormal_defecation | 1.17942635 |
70 | MP0010155_abnormal_intestine_physiology | 1.17236279 |
71 | MP0001545_abnormal_hematopoietic_system | 1.16317160 |
72 | MP0005397_hematopoietic_system_phenotyp | 1.16317160 |
73 | MP0005360_urolithiasis | 1.14934214 |
74 | MP0001346_abnormal_lacrimal_gland | 1.14313770 |
75 | MP0001666_abnormal_nutrient_absorption | 1.13870378 |
76 | MP0004142_abnormal_muscle_tone | 1.12594672 |
77 | MP0000566_synostosis | 1.10168067 |
78 | MP0002405_respiratory_system_inflammati | 1.07703033 |
79 | MP0002009_preneoplasia | 1.06743667 |
80 | MP0005319_abnormal_enzyme/_coenzyme | 1.06640845 |
81 | MP0003075_altered_response_to | 1.03836287 |
82 | MP0009763_increased_sensitivity_to | 1.03553677 |
83 | MP0001853_heart_inflammation | 1.01535839 |
84 | MP0005365_abnormal_bile_salt | 1.01473723 |
85 | MP0003186_abnormal_redox_activity | 1.00892664 |
86 | MP0000604_amyloidosis | 1.00473197 |
87 | MP0003303_peritoneal_inflammation | 0.99980345 |
88 | MP0004947_skin_inflammation | 0.99853413 |
89 | MP0005164_abnormal_response_to | 0.99582902 |
90 | MP0003448_altered_tumor_morphology | 0.98944111 |
91 | MP0000858_altered_metastatic_potential | 0.97349947 |
92 | MP0003011_delayed_dark_adaptation | 0.96713871 |
93 | MP0005409_darkened_coat_color | 0.96588665 |
94 | MP0010234_abnormal_vibrissa_follicle | 0.94402616 |
95 | MP0008004_abnormal_stomach_pH | 0.94104842 |
96 | MP0003183_abnormal_peptide_metabolism | 0.93579199 |
97 | MP0005167_abnormal_blood-brain_barrier | 0.92183311 |
98 | MP0002166_altered_tumor_susceptibility | 0.92151036 |
99 | MP0010329_abnormal_lipoprotein_level | 0.92148182 |
100 | MP0009697_abnormal_copulation | 0.92136202 |
101 | MP0004510_myositis | 0.90623673 |
102 | MP0001851_eye_inflammation | 0.90093730 |
103 | MP0000249_abnormal_blood_vessel | 0.89374027 |
104 | MP0008875_abnormal_xenobiotic_pharmacok | 0.89110964 |
105 | MP0010386_abnormal_urinary_bladder | 0.86441773 |
106 | MP0003828_pulmonary_edema | 0.86339360 |
107 | MP0010678_abnormal_skin_adnexa | 0.86237418 |
108 | MP0001764_abnormal_homeostasis | 0.84503050 |
109 | MP0002118_abnormal_lipid_homeostasis | 0.84247739 |
110 | MP0004808_abnormal_hematopoietic_stem | 0.83424538 |
111 | MP0005390_skeleton_phenotype | 0.81289260 |
112 | MP0001986_abnormal_taste_sensitivity | 0.80893068 |
113 | MP0002132_abnormal_respiratory_system | 0.80148221 |
114 | MP0005645_abnormal_hypothalamus_physiol | 0.79529158 |
115 | MP0005376_homeostasis/metabolism_phenot | 0.78719319 |
116 | MP0003252_abnormal_bile_duct | 0.78446392 |
117 | MP0002254_reproductive_system_inflammat | 0.77574135 |
118 | MP0003941_abnormal_skin_development | 0.77532356 |
119 | MP0003221_abnormal_cardiomyocyte_apopto | 0.76382267 |
120 | MP0005075_abnormal_melanosome_morpholog | 0.76266050 |
121 | MP0005647_abnormal_sex_gland | 0.74939237 |
122 | MP0001958_emphysema | 0.74479924 |
123 | MP0000716_abnormal_immune_system | 0.74298869 |
124 | MP0002638_abnormal_pupillary_reflex | 0.74000062 |
125 | MP0006036_abnormal_mitochondrial_physio | 0.73917789 |
126 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.73815306 |
127 | MP0003453_abnormal_keratinocyte_physiol | 0.72920582 |
128 | MP0000609_abnormal_liver_physiology | 0.72388027 |
129 | MP0010352_gastrointestinal_tract_polyps | 0.71850287 |
130 | MP0005408_hypopigmentation | 0.71645254 |
131 | MP0005166_decreased_susceptibility_to | 0.71058612 |
132 | MP0000372_irregular_coat_pigmentation | 0.69603985 |
133 | MP0001727_abnormal_embryo_implantation | 0.66218648 |
134 | MP0002019_abnormal_tumor_incidence | 0.64367677 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 5.87962220 |
2 | Recurrent bacterial skin infections (HP:0005406) | 5.42156322 |
3 | Eczematoid dermatitis (HP:0000976) | 4.47445341 |
4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.47444880 |
5 | Parakeratosis (HP:0001036) | 4.30625277 |
6 | Abnormality of macrophages (HP:0004311) | 4.27789502 |
7 | Gingivitis (HP:0000230) | 3.77007409 |
8 | Stomatitis (HP:0010280) | 3.70694757 |
9 | Systemic lupus erythematosus (HP:0002725) | 3.51991291 |
10 | Papillary thyroid carcinoma (HP:0002895) | 3.51282305 |
11 | Vacuolated lymphocytes (HP:0001922) | 3.47932693 |
12 | Recurrent skin infections (HP:0001581) | 3.47115063 |
13 | Prostate neoplasm (HP:0100787) | 3.43148106 |
14 | T lymphocytopenia (HP:0005403) | 3.31165072 |
15 | Thick nail (HP:0001805) | 3.26024989 |
16 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.15256982 |
17 | Abnormality of T cell number (HP:0011839) | 3.04020530 |
18 | Glomerulonephritis (HP:0000099) | 3.00327817 |
19 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.96805877 |
20 | Chronic obstructive pulmonary disease (HP:0006510) | 2.96010556 |
21 | Obstructive lung disease (HP:0006536) | 2.96010556 |
22 | Duplicated collecting system (HP:0000081) | 2.91131391 |
23 | Axonal loss (HP:0003447) | 2.90383417 |
24 | Prolonged bleeding time (HP:0003010) | 2.88448538 |
25 | Joint hemorrhage (HP:0005261) | 2.87979653 |
26 | Mediastinal lymphadenopathy (HP:0100721) | 2.87560779 |
27 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.82509377 |
28 | Optic neuritis (HP:0100653) | 2.78641178 |
29 | Retrobulbar optic neuritis (HP:0100654) | 2.78641178 |
30 | Disinhibition (HP:0000734) | 2.66852300 |
31 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.65991963 |
32 | Chromsome breakage (HP:0040012) | 2.63381439 |
33 | Encephalitis (HP:0002383) | 2.62766078 |
34 | Hepatosplenomegaly (HP:0001433) | 2.62041321 |
35 | Recurrent pneumonia (HP:0006532) | 2.61844122 |
36 | Loss of speech (HP:0002371) | 2.60510658 |
37 | Orchitis (HP:0100796) | 2.55218288 |
38 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.50888383 |
39 | Epistaxis (HP:0000421) | 2.50447161 |
40 | Metaphyseal dysplasia (HP:0100255) | 2.48779192 |
41 | Albinism (HP:0001022) | 2.46492237 |
42 | Prolonged neonatal jaundice (HP:0006579) | 2.42365742 |
43 | Periodontitis (HP:0000704) | 2.41859714 |
44 | Fair hair (HP:0002286) | 2.39741372 |
45 | Congenital sensorineural hearing impairment (HP:0008527) | 2.37745425 |
46 | Keratoconjunctivitis (HP:0001096) | 2.37386051 |
47 | Premature loss of primary teeth (HP:0006323) | 2.37031712 |
48 | Hypophosphatemic rickets (HP:0004912) | 2.36771534 |
49 | Prolonged partial thromboplastin time (HP:0003645) | 2.36630899 |
50 | Spontaneous hematomas (HP:0007420) | 2.36124780 |
51 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.34389186 |
52 | Abnormality of the renal collecting system (HP:0004742) | 2.33330197 |
53 | Conjugated hyperbilirubinemia (HP:0002908) | 2.32566289 |
54 | Pustule (HP:0200039) | 2.32378850 |
55 | Vasculitis (HP:0002633) | 2.31415979 |
56 | Abnormality of T cells (HP:0002843) | 2.28650396 |
57 | Thyroid carcinoma (HP:0002890) | 2.28644216 |
58 | Vascular calcification (HP:0004934) | 2.28362476 |
59 | Abnormality of the common coagulation pathway (HP:0010990) | 2.28064969 |
60 | Myositis (HP:0100614) | 2.27610982 |
61 | Recurrent fungal infections (HP:0002841) | 2.24946157 |
62 | Degeneration of anterior horn cells (HP:0002398) | 2.22084537 |
63 | Abnormality of the anterior horn cell (HP:0006802) | 2.22084537 |
64 | Amyloidosis (HP:0011034) | 2.21308019 |
65 | Patchy hypopigmentation of hair (HP:0011365) | 2.18962830 |
66 | Anhidrosis (HP:0000970) | 2.18846129 |
67 | Autoimmune thrombocytopenia (HP:0001973) | 2.18517883 |
68 | Autoimmune hemolytic anemia (HP:0001890) | 2.18060284 |
69 | Neurofibrillary tangles (HP:0002185) | 2.18044222 |
70 | Recurrent viral infections (HP:0004429) | 2.17890209 |
71 | Increased cerebral lipofuscin (HP:0011813) | 2.17854122 |
72 | White forelock (HP:0002211) | 2.17250838 |
73 | IgM deficiency (HP:0002850) | 2.15410020 |
74 | Termporal pattern (HP:0011008) | 2.14654581 |
75 | Insidious onset (HP:0003587) | 2.14654581 |
76 | Gingival bleeding (HP:0000225) | 2.13908804 |
77 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.13090217 |
78 | Myocardial infarction (HP:0001658) | 2.13010180 |
79 | Xerostomia (HP:0000217) | 2.11893962 |
80 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.11633595 |
81 | Erythroderma (HP:0001019) | 2.10521605 |
82 | Petechiae (HP:0000967) | 2.09249166 |
83 | B lymphocytopenia (HP:0010976) | 2.07939370 |
84 | Abnormality of B cell number (HP:0010975) | 2.07508176 |
85 | Renal cortical cysts (HP:0000803) | 2.05686795 |
86 | Peripheral demyelination (HP:0011096) | 2.05111325 |
87 | Panhypogammaglobulinemia (HP:0003139) | 2.04804313 |
88 | Scanning speech (HP:0002168) | 2.04189199 |
89 | Generalized hypopigmentation of hair (HP:0011358) | 2.00741242 |
90 | Granulocytopenia (HP:0001913) | 2.00594673 |
91 | Bone pain (HP:0002653) | 2.00477942 |
92 | Arterial thrombosis (HP:0004420) | 1.98642245 |
93 | Stomach cancer (HP:0012126) | 1.98555697 |
94 | Aplasia cutis congenita (HP:0001057) | 1.98291434 |
95 | Urticaria (HP:0001025) | 1.98119419 |
96 | Pulmonary embolism (HP:0002204) | 1.98077823 |
97 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.98061113 |
98 | Inflammation of the large intestine (HP:0002037) | 1.97852693 |
99 | Lower limb hyperreflexia (HP:0002395) | 1.97512132 |
100 | Nephritis (HP:0000123) | 1.96676103 |
101 | Gastrointestinal infarctions (HP:0005244) | 1.96663275 |
102 | Abnormality of glycolipid metabolism (HP:0010969) | 1.95288226 |
103 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.95288226 |
104 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.95288226 |
105 | Cardiovascular calcification (HP:0011915) | 1.95234100 |
106 | Joint swelling (HP:0001386) | 1.94449295 |
107 | Gangrene (HP:0100758) | 1.94284859 |
108 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.93988807 |
109 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.93988807 |
110 | Osteomyelitis (HP:0002754) | 1.93508437 |
111 | Polyneuropathy (HP:0001271) | 1.91882993 |
112 | Mitral stenosis (HP:0001718) | 1.91403766 |
113 | Recurrent bronchitis (HP:0002837) | 1.90277119 |
114 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.89851258 |
115 | Acute hepatic failure (HP:0006554) | 1.89306560 |
116 | Cone-rod dystrophy (HP:0000548) | 1.89029706 |
117 | Viral hepatitis (HP:0006562) | 1.88823511 |
118 | Abnormality of iron homeostasis (HP:0011031) | 1.88770713 |
119 | Amyotrophic lateral sclerosis (HP:0007354) | 1.88678813 |
120 | Leukocytosis (HP:0001974) | 1.88306707 |
121 | Acute myeloid leukemia (HP:0004808) | 1.88014916 |
122 | Onion bulb formation (HP:0003383) | 1.87881846 |
123 | Reduced antithrombin III activity (HP:0001976) | 1.87866175 |
124 | Episodic fever (HP:0001954) | 1.87759846 |
125 | Abnormal biliary tract physiology (HP:0012439) | 1.86665723 |
126 | Bile duct proliferation (HP:0001408) | 1.86665723 |
127 | Cheilitis (HP:0100825) | 1.86602512 |
128 | Sensory axonal neuropathy (HP:0003390) | 1.86575063 |
129 | Chest pain (HP:0100749) | 1.86460133 |
130 | Complement deficiency (HP:0004431) | 1.85147918 |
131 | Gastrointestinal inflammation (HP:0004386) | 1.84742893 |
132 | Abnormal spermatogenesis (HP:0008669) | 1.84605584 |
133 | Progressive visual loss (HP:0000529) | 1.83894743 |
134 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.83860676 |
135 | Recurrent cutaneous fungal infections (HP:0011370) | 1.83860676 |
136 | Tubulointerstitial nephritis (HP:0001970) | 1.82988523 |
137 | Eosinophilia (HP:0001880) | 1.82865104 |
138 | Abnormality of the prostate (HP:0008775) | 1.81766053 |
139 | Hyporeflexia of lower limbs (HP:0002600) | 1.81485113 |
140 | Intrahepatic cholestasis (HP:0001406) | 1.80978668 |
141 | IgG deficiency (HP:0004315) | 1.80922451 |
142 | Recurrent lower respiratory tract infections (HP:0002783) | 1.80365062 |
143 | Agnosia (HP:0010524) | 1.80232344 |
144 | Abnormality of T cell physiology (HP:0011840) | 1.79867047 |
145 | Subacute progressive viral hepatitis (HP:0006572) | 1.79394432 |
146 | Ectropion (HP:0000656) | 1.79019039 |
147 | Conjunctival telangiectasia (HP:0000524) | 1.79018151 |
148 | Basal ganglia calcification (HP:0002135) | 1.78758138 |
149 | Meningitis (HP:0001287) | 1.77931413 |
150 | Purpura (HP:0000979) | 1.77801811 |
151 | Keratoconjunctivitis sicca (HP:0001097) | 1.77697834 |
152 | Osteomalacia (HP:0002749) | 1.76913207 |
153 | Abnormality of the axillary hair (HP:0100134) | 1.76029235 |
154 | Abnormality of secondary sexual hair (HP:0009888) | 1.76029235 |
155 | Submucous cleft hard palate (HP:0000176) | 1.75974464 |
156 | Slow saccadic eye movements (HP:0000514) | 1.73579116 |
157 | Upper limb muscle weakness (HP:0003484) | 1.73536443 |
158 | Pruritus (HP:0000989) | 1.69887180 |
159 | Conical tooth (HP:0000698) | 1.69875634 |
160 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.69532256 |
161 | Akinesia (HP:0002304) | 1.68188805 |
162 | Chronic diarrhea (HP:0002028) | 1.65442635 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K14 | 3.73133506 |
2 | IRAK4 | 3.11541533 |
3 | RIPK4 | 3.03495424 |
4 | BLK | 3.00573210 |
5 | PBK | 2.93303827 |
6 | IRAK3 | 2.58794033 |
7 | CASK | 2.46429043 |
8 | MST4 | 2.34729958 |
9 | PDK2 | 2.29448175 |
10 | IKBKE | 2.25106597 |
11 | ADRBK2 | 2.20801646 |
12 | GRK6 | 2.15595107 |
13 | SIK3 | 2.07581803 |
14 | GRK7 | 2.03057541 |
15 | STK39 | 1.94877299 |
16 | EPHB1 | 1.93660236 |
17 | EIF2AK2 | 1.86715613 |
18 | PRPF4B | 1.85881355 |
19 | PKN1 | 1.83964055 |
20 | TXK | 1.83044542 |
21 | TBK1 | 1.82747679 |
22 | YES1 | 1.82487787 |
23 | MAP3K2 | 1.81542867 |
24 | TYK2 | 1.81201897 |
25 | FGR | 1.75588232 |
26 | TRPM7 | 1.74614616 |
27 | IKBKB | 1.72794965 |
28 | MAP4K1 | 1.70816256 |
29 | WNK4 | 1.68161616 |
30 | OXSR1 | 1.63360986 |
31 | GRK1 | 1.61926303 |
32 | ITK | 1.59474030 |
33 | TRIM28 | 1.58739237 |
34 | KSR2 | 1.58106476 |
35 | BMPR2 | 1.56390329 |
36 | INSRR | 1.51638413 |
37 | EIF2AK3 | 1.45786302 |
38 | RAF1 | 1.45628414 |
39 | FRK | 1.40366737 |
40 | CLK1 | 1.37243059 |
41 | FGFR3 | 1.34518193 |
42 | BMPR1B | 1.33775177 |
43 | MAP2K3 | 1.33707735 |
44 | NUAK1 | 1.33234243 |
45 | EPHA2 | 1.28610785 |
46 | STK24 | 1.28480282 |
47 | MARK3 | 1.27885595 |
48 | ZAK | 1.27862265 |
49 | CSK | 1.27468943 |
50 | TAOK3 | 1.23899071 |
51 | MST1R | 1.21968197 |
52 | KIT | 1.15977206 |
53 | JAK1 | 1.15815753 |
54 | STK10 | 1.15584544 |
55 | MAP3K3 | 1.08518815 |
56 | KSR1 | 1.06882558 |
57 | BRD4 | 1.06627934 |
58 | PTK2B | 1.05741183 |
59 | PIK3CG | 1.03859308 |
60 | BCR | 1.01208571 |
61 | MAPKAPK5 | 0.99328250 |
62 | ACVR1B | 0.94864087 |
63 | JAK3 | 0.91835719 |
64 | ERBB4 | 0.90900060 |
65 | LYN | 0.90809804 |
66 | MAPK7 | 0.87967440 |
67 | MAP3K12 | 0.86039111 |
68 | MAP3K1 | 0.84533454 |
69 | SGK494 | 0.83842766 |
70 | SGK223 | 0.83842766 |
71 | LCK | 0.82328631 |
72 | HCK | 0.82309167 |
73 | MATK | 0.81345161 |
74 | PRKCE | 0.78755683 |
75 | MET | 0.78296979 |
76 | NEK9 | 0.77681023 |
77 | CDK9 | 0.77067098 |
78 | IRAK2 | 0.76617701 |
79 | ARAF | 0.75755074 |
80 | TNK2 | 0.74102569 |
81 | PRKCQ | 0.72906541 |
82 | TEC | 0.72624369 |
83 | CSF1R | 0.71895060 |
84 | ABL1 | 0.68085780 |
85 | CAMK1D | 0.65646962 |
86 | PDK1 | 0.64595691 |
87 | MAP3K5 | 0.63642616 |
88 | CDK6 | 0.62741250 |
89 | NEK6 | 0.62343644 |
90 | SYK | 0.62253775 |
91 | MAPK15 | 0.61702910 |
92 | MUSK | 0.60923178 |
93 | MAPK12 | 0.60157229 |
94 | PIM2 | 0.59957030 |
95 | TNIK | 0.59591286 |
96 | CHUK | 0.59243168 |
97 | LATS1 | 0.58180681 |
98 | NLK | 0.57794472 |
99 | STK4 | 0.57734533 |
100 | SGK2 | 0.57289535 |
101 | FGFR2 | 0.56828942 |
102 | FES | 0.56498862 |
103 | PRKAA2 | 0.55234916 |
104 | PRKCD | 0.54648215 |
105 | PIK3CA | 0.54619059 |
106 | CAMK2D | 0.54500458 |
107 | JAK2 | 0.54486953 |
108 | ERN1 | 0.52478805 |
109 | PDPK1 | 0.48630820 |
110 | RPS6KA5 | 0.48550882 |
111 | IRAK1 | 0.47925262 |
112 | GSK3A | 0.47737588 |
113 | CAMK2B | 0.47357612 |
114 | ERBB3 | 0.46969044 |
115 | BRSK2 | 0.46699040 |
116 | PRKG1 | 0.45295025 |
117 | TGFBR2 | 0.44671318 |
118 | MAPKAPK2 | 0.43521906 |
119 | EIF2AK1 | 0.43132537 |
120 | MAP3K13 | 0.41307783 |
121 | IGF1R | 0.39594770 |
122 | MAPK4 | 0.39343378 |
123 | EPHA3 | 0.38957958 |
124 | BTK | 0.38474532 |
125 | WNK1 | 0.38403220 |
126 | AKT3 | 0.38250943 |
127 | MOS | 0.38069786 |
128 | SGK1 | 0.37913274 |
129 | PRKD1 | 0.37087392 |
130 | CDK3 | 0.36600671 |
131 | ZAP70 | 0.36594147 |
132 | CCNB1 | 0.36161110 |
133 | OBSCN | 0.36060061 |
134 | CAMK2G | 0.35249215 |
135 | MAPK11 | 0.35131519 |
136 | STK16 | 0.34791548 |
137 | CAMKK2 | 0.34785417 |
138 | STK3 | 0.34427374 |
139 | CAMK1G | 0.34373977 |
140 | EGFR | 0.33665788 |
141 | PIM1 | 0.33496043 |
142 | SCYL2 | 0.33296238 |
143 | CAMK2A | 0.32610452 |
144 | FGFR4 | 0.31504957 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.19451738 |
2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.15810316 |
3 | Histidine metabolism_Homo sapiens_hsa00340 | 2.23739743 |
4 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.22615761 |
5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.22429399 |
6 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.06043156 |
7 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.02624466 |
8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.91335748 |
9 | Pertussis_Homo sapiens_hsa05133 | 1.88634297 |
10 | Leishmaniasis_Homo sapiens_hsa05140 | 1.87066345 |
11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.76126833 |
12 | Allograft rejection_Homo sapiens_hsa05330 | 1.75494906 |
13 | Phagosome_Homo sapiens_hsa04145 | 1.74730308 |
14 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.71903529 |
15 | Lysosome_Homo sapiens_hsa04142 | 1.68816755 |
16 | Malaria_Homo sapiens_hsa05144 | 1.63467580 |
17 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.62255975 |
18 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.60808042 |
19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.56454011 |
20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.53287064 |
21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.51290933 |
22 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.50808304 |
23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.50075401 |
24 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.49668801 |
25 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.46293573 |
26 | Mineral absorption_Homo sapiens_hsa04978 | 1.43557325 |
27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.41299961 |
28 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.41141632 |
29 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.40820997 |
30 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.38467583 |
31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.37948972 |
32 | Shigellosis_Homo sapiens_hsa05131 | 1.37535257 |
33 | Asthma_Homo sapiens_hsa05310 | 1.37291519 |
34 | Other glycan degradation_Homo sapiens_hsa00511 | 1.36623503 |
35 | Platelet activation_Homo sapiens_hsa04611 | 1.35240342 |
36 | Tuberculosis_Homo sapiens_hsa05152 | 1.35147264 |
37 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.34597330 |
38 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.33393074 |
39 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.29126816 |
40 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.28081535 |
41 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.24211726 |
42 | ABC transporters_Homo sapiens_hsa02010 | 1.22667460 |
43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.20753519 |
44 | Peroxisome_Homo sapiens_hsa04146 | 1.20373436 |
45 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.19739523 |
46 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.17957669 |
47 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.16834808 |
48 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.15300185 |
49 | Legionellosis_Homo sapiens_hsa05134 | 1.14445732 |
50 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.14427577 |
51 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.13871487 |
52 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.13625524 |
53 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.13201178 |
54 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.11912110 |
55 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.11614656 |
56 | Hepatitis B_Homo sapiens_hsa05161 | 1.10703250 |
57 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.10416868 |
58 | Measles_Homo sapiens_hsa05162 | 1.09734955 |
59 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.09566526 |
60 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.08717203 |
61 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.08656959 |
62 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.08601106 |
63 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.06560855 |
64 | Retinol metabolism_Homo sapiens_hsa00830 | 1.03789283 |
65 | Viral myocarditis_Homo sapiens_hsa05416 | 1.02860281 |
66 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.02762204 |
67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.01855817 |
68 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.99425651 |
69 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.98229675 |
70 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.96689497 |
71 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.95608741 |
72 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.92492973 |
73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.90372944 |
74 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.89323060 |
75 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.88778030 |
76 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.88482286 |
77 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.88372780 |
78 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.87206865 |
79 | * Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.86929330 |
80 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.85732014 |
81 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.85697538 |
82 | Salmonella infection_Homo sapiens_hsa05132 | 0.84788830 |
83 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.84334363 |
84 | * Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.82864377 |
85 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.81968722 |
86 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.81749632 |
87 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.81258753 |
88 | Influenza A_Homo sapiens_hsa05164 | 0.80675614 |
89 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.80305352 |
90 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.80147160 |
91 | Hepatitis C_Homo sapiens_hsa05160 | 0.78391835 |
92 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.78299549 |
93 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.77709237 |
94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.77344437 |
95 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.76924968 |
96 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.72021952 |
97 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.71199288 |
98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.70191715 |
99 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.69813188 |
100 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.69398980 |
101 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.69097304 |
102 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.66533143 |
103 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.65282314 |
104 | Circadian rhythm_Homo sapiens_hsa04710 | 0.64492415 |
105 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.63208320 |
106 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.62331397 |
107 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.61471122 |
108 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58317718 |
109 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.57877873 |
110 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.55696000 |
111 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.55067710 |
112 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.54492209 |
113 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.54361472 |
114 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54300621 |
115 | Insulin resistance_Homo sapiens_hsa04931 | 0.54076223 |
116 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.51252805 |
117 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.50855938 |
118 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.48136931 |
119 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47813688 |
120 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.46545302 |
121 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.45912248 |
122 | Apoptosis_Homo sapiens_hsa04210 | 0.45051416 |
123 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45038470 |
124 | Protein export_Homo sapiens_hsa03060 | 0.44014566 |
125 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.43343251 |
126 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42461270 |
127 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.42444948 |
128 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.41881213 |
129 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.41365304 |
130 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.40733645 |
131 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.39980315 |
132 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.39672158 |
133 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38845515 |